Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-1,142
Closed -$4K 2056
2022
Q1
$4K Buy
+1,142
New +$7.36K ﹤0.01% 1692
2021
Q2
Sell
-257
Closed -$6K 2039
2021
Q1
$6K Buy
+257
New +$5.93K ﹤0.01% 1637
2020
Q4
Sell
-498
Closed -$13K 1811
2020
Q3
$13K Buy
+498
New +$15.8K ﹤0.01% 949

Other funds holding ETNB

Point72 Hong Kong's ETNB Position: Q2 2022 in Review

Point72 Hong Kong sold out of 89bio (ETNB) in Q2 2022, closing a stake of 1,142 shares — an estimated $4K sold.

Point72 Hong Kong first reported a position in ETNB in Q3 2020 and held it in 3 quarters. The position peaked at $13K in Q3 2020. 70 funds tracked by Wall St. Rank hold ETNB as of Q2 2022.

  • Point72 Hong Kong reported no remaining 89bio position as of Q2 2022 after selling out during the quarter.
  • Point72 Hong Kong sold 1,142 89bio shares in Q2 2022, an estimated $4K.
  • Point72 Hong Kong first reported a position in 89bio in Q3 2020 and held it in 3 quarters.
  • Point72 Hong Kong's 89bio position peaked at $13K in Q3 2020.
  • 70 funds tracked by Wall St. Rank held 89bio as of Q2 2022.

Based on Point72 Hong Kong's 13F filing for Q2 2022, filed 15 Aug 2022.